Proacta extends clinical trials in New Zealand

Thursday, 8 February 2007, 2:17 pm | Proacta

NEW ZEALAND, Thursday February 8, 2007 - Proacta Inc, an oncology drug discovery and development company, announced today that it has raised a further US$35m in a Series B round of funding. This new funding will be used to take New Zealand-discovered ... More >>